Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.78 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.78 |
| ▸ | PTGES | O14684 | 3/20 | 0.77 |
| ▸ | TOP2A | P11388 | 1/20 | 0.77 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.64 |
| ▸ | BID | P55957 | 3/20 | 0.60 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.60 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.60 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.60 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.60 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.60 |
| ▸ | PPARG | P37231 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 1/20 | 0.60 |
| ▸ | EP300 | Q09472 | 1/20 | 0.60 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.60 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.60 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 2/20 | 0.52 |
| ▸ | F7 | P08709 | 2/20 | 0.52 |
| ▸ | F3 | P13726 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367141 | 1.00 | PTPN1 (0.78) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL28206687 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL29647786 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL2557659 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL34463357 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL24511794 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL29635011 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL34463305 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL26725572 | 0.98 | PTPN1 (0.76) | PTPN1PTPN11PTGESTOP2APTPN2 | |
| SCHEMBL30261073 | 0.95 | PTPN1 (0.81) | PTPN1PTPN11PTGESTOP2APTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613231-B | Preparation method of cannabidiol | 山东新华制药股份有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119613231-A | Preparation method of cannabidiol | 山东新华制药股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-114555797-B | Biosynthesis of cannabinoid precursors using aromatic prenyl transferases | 新加坡国立大学 | 2024-10-01 | — | — | CN | claimed |
| US-20240084337-A1 | BIOSYNTHESIS OF CANNABINOID PRECURSORS USING NOVEL AROMATIC PRENYL TRANSFERASES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2024-03-14 | — | — | US | claimed |
| CN-115677456-B | Preparation method of cannabidiol | 暨明医药科技（苏州）有限公司 | 2023-12-08 | — | — | CN | claimed |
| EP-4229026-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | Consort Medical Limited (GB) | 2023-08-23 | — | — | EP | claimed |
| CN-115677456-A | Preparation method of cannabidiol | 暨明医药科技（苏州）有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-20230029027-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. | 2023-01-26 | — | — | US | claimed |
| EP-4041875-A1 | BIOSYNTHESIS OF CANNABINOID PRECURSORS USING NOVEL AROMATIC PRENYL TRANSFERASES | National University of Singapore (SG) | 2022-08-17 | — | — | EP | claimed |
| CN-114555797-A | Biosynthesis of cannabinoid precursors using novel aromatic prenyltransferases | 新加坡国立大学 | 2022-05-27 | — | — | CN | claimed |
| WO-2022084662-A1 | PROCESS FOR THE PREPARATION OF CANNABIDIOL | Consort Medical Limited (GB) | 2022-04-28 | — | — | WO | claimed |
| CN-113584089-A | Application of prenyl transferase in catalytic synthesis of cannabigerol or cannabigerol acid | 嘉兴欣贝莱生物科技有限公司 | 2021-11-02 | — | — | CN | claimed |
| WO-2021071437-A1 | BIOSYNTHESIS OF CANNABINOID PRECURSORS USING NOVEL AROMATIC PRENYL TRANSFERASES | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2021-04-15 | — | — | WO | claimed |
| WO-2020210810-A9 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-11-26 | — | — | WO | claimed |
| WO-2020210810-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-10-15 | — | — | WO | claimed |
| WO-2019183152-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2019-09-26 | — | — | WO | claimed |
| US-20260144806-A1 | FORMULATION AND NONCOVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES | MINGOWOOD PHARMACAL LLC (US) | 2026-05-28 | — | — | US | disclosed |
| US-12617747-B2 | Cannabinoid analogs and methods for their preparation | INMED PHARMACEUTICALS INC. (CA) | 2026-05-05 | — | — | US | disclosed |
| US-7807711-B2 | Medicinal acidic cannabinoids | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2010-10-05 | — | — | US | disclosed |
| US-20070032544-A1 | MEDICINAL ACIDIC CANNABINOIDS | NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617747-B2 | Cannabinoid analogs and methods for their preparation | CNR2, CNR1, FAAH | PTPN1 4104/4885PTPN11 4460/4885PTGES 2504/4885 |
| US-20070032544-A1 | MEDICINAL ACIDIC CANNABINOIDS | CNR2, CNR1, ARFGEF1 | PTPN1 4208/4885PTPN11 3804/4885PTGES 87/4885 |
| US-20260144806-A1 | FORMULATION AND NONCOVALENT STABILIZATION OF OLIVETOLIC ACID DERIVATIVES | LDHA, LDHB, FAAH | PTPN1 4538/4885PTPN11 4468/4885PTGES 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.